1. Home
  2. IKNA vs WPRT Comparison

IKNA vs WPRT Comparison

Compare IKNA & WPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • WPRT
  • Stock Information
  • Founded
  • IKNA 2016
  • WPRT 1995
  • Country
  • IKNA United States
  • WPRT Canada
  • Employees
  • IKNA N/A
  • WPRT N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • WPRT Industrial Machinery/Components
  • Sector
  • IKNA Health Care
  • WPRT Industrials
  • Exchange
  • IKNA Nasdaq
  • WPRT Nasdaq
  • Market Cap
  • IKNA 61.8M
  • WPRT 49.9M
  • IPO Year
  • IKNA 2021
  • WPRT 1995
  • Fundamental
  • Price
  • IKNA $1.35
  • WPRT $3.06
  • Analyst Decision
  • IKNA Strong Buy
  • WPRT Buy
  • Analyst Count
  • IKNA 1
  • WPRT 3
  • Target Price
  • IKNA $4.00
  • WPRT $6.33
  • AVG Volume (30 Days)
  • IKNA 79.7K
  • WPRT 15.2K
  • Earning Date
  • IKNA 08-07-2025
  • WPRT 08-11-2025
  • Dividend Yield
  • IKNA N/A
  • WPRT N/A
  • EPS Growth
  • IKNA N/A
  • WPRT N/A
  • EPS
  • IKNA N/A
  • WPRT N/A
  • Revenue
  • IKNA N/A
  • WPRT $295,680,000.00
  • Revenue This Year
  • IKNA N/A
  • WPRT N/A
  • Revenue Next Year
  • IKNA N/A
  • WPRT N/A
  • P/E Ratio
  • IKNA N/A
  • WPRT N/A
  • Revenue Growth
  • IKNA N/A
  • WPRT N/A
  • 52 Week Low
  • IKNA $0.97
  • WPRT $2.50
  • 52 Week High
  • IKNA $1.94
  • WPRT $6.50
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 53.36
  • WPRT 53.05
  • Support Level
  • IKNA $1.31
  • WPRT $2.96
  • Resistance Level
  • IKNA $1.38
  • WPRT $3.15
  • Average True Range (ATR)
  • IKNA 0.06
  • WPRT 0.12
  • MACD
  • IKNA -0.01
  • WPRT 0.02
  • Stochastic Oscillator
  • IKNA 15.79
  • WPRT 51.22

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.

Share on Social Networks: